Bioresorbable Vascular Scaffold Degradation Kinetics and Endothelialisation: A Preclinical Study

Authors

DOI:

https://doi.org/10.5281/zenodo.22642709

Keywords:

bioresorbable vascular scaffold, scaffold degradation kinetics, endothelialisation, magnesium alloy scaffold, preclinical coronary artery model

Abstract

Background: A fully bioresorbable vascular scaffold is intended to provide temporary radial support during arterial healing and then disappear, restoring vasomotion and avoiding the long-term liabilities of a permanent metallic implant, but realising this concept depends on degradation kinetics and endothelialisation timelines that can only be characterised serially in preclinical animal models. Objective: This narrative review synthesises published porcine and rabbit arterial implantation studies of bioresorbable vascular scaffolds to characterise their degradation kinetics and endothelialisation/re-endothelialisation profiles. Methods: We reviewed preclinical coronary and peripheral artery studies of polymeric (PLLA, PLLA/PLGA blend, tyrosine-derived polycarbonate) and magnesium-alloy bioresorbable scaffold platforms, focusing on serially reported structural degradation timelines and histological or scanning electron microscopy-based endothelial coverage data. Findings: PLLA-based polymer scaffolds degrade over a relatively homogeneous multi-year hydrolytic window of roughly two to four years, whereas magnesium-alloy platforms span a much broader corrosion-driven range from under three months in first-generation designs to twelve to twenty-six months in optimised second-generation and experimental scaffolds; head-to-head rabbit iliac artery data indicate magnesium-based scaffolds achieve earlier and more complete endothelial coverage than PLLA scaffolds at matched early time points, while newer tuned polymer blends are narrowing this gap. Conclusions: Preclinical degradation and endothelialisation data remain essential for guiding rational bioresorbable scaffold material and strut-architecture design and for anticipating the thrombotic risk windows that have historically emerged during large randomised clinical trials.

References

Onuma Y, Serruys PW (2018). Fully bioresorbable vascular scaffolds: lessons learned and future directions. Nature Reviews Cardiology, 15(8), 447-448. DOI: 10.1038/s41569-018-0124-7.

Onuma Y, Serruys PW, Perkins LE, Okamura T, Gonzalo N, García-García HM, Regar E, Kamberi M, Powers JC, Rapoza R, van Beusekom H, van der Giessen W, Virmani R (2014). Decade of histological follow-up for a fully biodegradable poly-L-lactic acid coronary stent (Igaki-Tamai stent) in humans: are bioresorbable scaffolds the answer? Circulation, 129(1), 110-115. DOI: 10.1161/CIRCULATIONAHA.113.003769.

Otsuka F, Pacheco E, Perkins LE, Lane JP, Wang Q, Kamberi M, Frie M, Wang J, Sakakura K, Yahagi K, Ladich E, Rapoza RJ, Kolodgie FD, Virmani R (2014). Long-term safety of an everolimus-eluting bioresorbable vascular scaffold and the cobalt-chromium XIENCE V stent in a porcine coronary artery model. Circulation: Cardiovascular Interventions, 7(3), 330-342. DOI: 10.1161/CIRCINTERVENTIONS.113.000990.

Tamai H, Igaki K, Kyo E, Kosuga K, Kawashima A, Matsui S, Komori H, Tsuji T, Motohara S, Uehata H (2000). Initial and 6-month results of biodegradable poly-l-lactic acid coronary stents in humans. Circulation, 102(4), 399-404. DOI: 10.1161/01.CIR.102.4.399.

Nishio S, Kosuga K, Igaki K, Okada M, Kyo E, Tsuji T, Takeuchi E, Inuzuka Y, Takeda S, Hata T, Takeuchi Y, Kawada Y, Harita T, Seki J, Akamatsu S, Hasegawa S, Bruining N, Brugaletta S, de Winter S, Muramatsu T, Onuma Y, Serruys PW, Ikeguchi S (2012). Long-term (>10 years) clinical outcomes of first-in-human biodegradable poly-l-lactic acid coronary stents: Igaki-Tamai stents. Circulation, 125(19), 2343-2353. DOI: 10.1161/CIRCULATIONAHA.110.000901.

Erbel R, Di Mario C, Bartunek J, Bonnier J, de Bruyne B, Eberli FR, Erne P, Haude M, Heublein B, Horrigan M, Ilsley C, Böse D, Koolen J, Lüscher TF, Weissman N, Waksman R (2007). Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: a prospective, non-randomised multicentre trial. The Lancet, 369(9576), 1869-1875. DOI: 10.1016/S0140-6736(07)60853-8.

Waksman R, Pakala R, Kuchulakanti PK, Baffour R, Hellinga D, Seabron R, Tio FO, Wittchow E, Hartwig S, Harder C, Rohde R, Heublein B, Andreae A, Waldmann KH, Haverich A (2006). Safety and efficacy of bioabsorbable magnesium alloy stents in porcine coronary arteries. Catheterization and Cardiovascular Interventions, 68(4), 607-617. DOI: 10.1002/ccd.20727.

Pinto Slottow TL, Pakala R, Waksman R (2008). Serial imaging and histology illustrating the degradation of a bioabsorbable magnesium stent in a porcine coronary artery. European Heart Journal, 29(3), 314. DOI: 10.1093/eurheartj/ehm365.

Vorpahl M, Nakano M, Perkins LE, Otsuka F, Jones R, Acampado E, Lane JP, Rapoza R, Kolodgie FD, Virmani R (2014). Vascular healing and integration of a fully bioresorbable everolimus-eluting scaffold in a rabbit iliac arterial model. EuroIntervention, 10(7), 833-841. DOI:

4244/EIJV10I7A143. 10. Waksman R, Zumstein P, Pritsch M, Wittchow E, Haude M, Lapointe-Corriveau C, Leclerc G, Joner M (2017). Second-generation magnesium scaffold Magmaris: device design and preclinical evaluation in a porcine coronary artery model. EuroIntervention, 13(4), 440-449. DOI: 10.4244/EIJ-D-16-00915.

Grabow N, Bünger CM, Schultze C, Schmohl K, Martin DP, Williams SF, Sternberg K, Schmitz KP (2022). Development of biodegradable polymeric stents for the treatment of cardiovascular diseases. Biomaterials Research, 26, article 41.

Kachel M, Melo PHC, Cheng Y, Conditt GB, Gram D, Anderson J, Rousselle SD, Parikh SA, Granada JF, Kaluza GL (2025). The preclinical study of biocompatibility of tyrosine polycarbonate bioresorbable scaffold in small caliber porcine peripheral arteries. Scientific Reports, 15, article 10624. DOI: 10.1038/s41598-025-91759-6.

Buszman PP, Kachel M, Łukasik K, Nożyński J, Skowronek R, Grajek M, Michalak M, Sobota M, Kasperczyk J, Małachowski J, Sybilski K, Mazur M, Kaźmierczak P, Milewski KP, Buszman PE (2025). Improved vascular response to a novel polymeric blend PLLA/PLGA coronary scaffold material: preclinical study. Scientific Reports, 15, article 34219. DOI: 10.1038/s41598-025-15997-4.

Haude M, Ince H, Abizaid A, Toelg R, Lemos PA, von Birgelen C, Christiansen EH, Wijns W, Neumann FJ, Kaiser C, Eeckhout E, Lim ST, Escaned J, Garcia-Garcia HM, Waksman R (2016). Sustained safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary lesions: 12-month clinical results and angiographic findings of the BIOSOLVE-II first-in-man trial. European Heart Journal, 37(35), 2701-2709.

Torii S, Yamamoto A, Yoshikawa A, Lu L, Sasaki M, Obuchi S, Wada A, Tsukamoto H, Nakazawa G (2024). Degradation of a novel magnesium alloy-based bioresorbable coronary scaffold in a swine coronary artery model. Cardiovascular Intervention and Therapeutics, 39(4), 428-437. DOI: 10.1007/s12928-024-01023-3.

Zhu J, Zhang X, Niu J, Shi Y, Zhu Z, Dai D, Chen C, Pei J, Yuan G, Zhang R (2021). Biosafety and efficacy evaluation of a biodegradable magnesium-based drug-eluting stent in porcine coronary artery. Scientific Reports, 11, article 7330. DOI: 10.1038/s41598-021-86803-0.

Obayi CS, Tolouei R, Paternoster C, Turgeon S, Okorie BA, Obikwelu DO, Mantovani D (2020). Are Fe-based stenting materials biocompatible? A critical review of in vitro and in vivo studies. Journal of Functional Biomaterials, 11(2), 39.

Ijichi T, Nakazawa G, Torii S, Nagamatsu H, Yoshikawa A, Souba J, Isobe A, Hagiwara H, Ikari Y (2019). Comparisons of early vascular reactions in biodegradable and durable polymer-based drug-eluting stents in the porcine coronary artery. PLOS ONE, 14(1), e0209841. DOI: 10.1371/journal.pone.0209841.

Park DS, Jeong MH, Jin YJ, Na MH, Sim DS, Kim M, Cho KH, Hyun DY, Oh S, Kim JH, Lim KS, Park JK, Kim HK, Hong YJ, Kim JH, Ahn Y, Kim JH (2023). Preclinical evaluation of an everolimus-eluting bioresorbable vascular scaffold via a long-term rabbit iliac artery model. Tissue Engineering and Regenerative Medicine, 20(2), 239-249. DOI: 10.1007/s13770-023-00518-z.

Kraak RP, de Boer HH, Elias J, Ambarus CA, van der Wal AC, de Winter RJ, Wykrzykowska JJ (2015). Coronary artery vessel healing pattern, short and long term, after implantation of the everolimus-eluting bioresorbable vascular scaffold. Journal of the American Heart Association, 4(11), e002551. DOI: 10.1161/JAHA.115.002551.

Verheye S, Wlodarczak A, Montorsi P, Torzewski J, Bennett J, Haude M, Starmer G, Buck T, Ferdinande B, Nef H, Vermeersch P, Wiemer M, Uzun G, Ince H (2021). Twelve-month outcomes of 400 patients treated with a resorbable magnesium scaffold: insights from the BIOSOLVE-IV registry. EuroIntervention, 17(10), 823-832.

Yamaji K, Ueki Y, Souteyrand G, Daemen J, Wiebe J, Nef H, Adriaenssens T, Loh JP, Lattuca B, Wykrzykowska JJ, Gutierrez-Chico JL, Onuma Y, Radu MD, Räber L (2017). Mechanisms of very late bioresorbable scaffold thrombosis: the INVEST registry. Journal of the American College of Cardiology, 70(19), 2330-2344. DOI: 10.1016/j.jacc.2017.09.014.

Serruys PW, Chevalier B, Sotomi Y, Cequier A, Carrié D, Piek JJ, Van Boven AJ, Dominici M, Dudek D, McClean D, Helqvist S, Haude M, Reith S, de Sousa Almeida M, Campo G, Iñiguez A, Sabaté M, Windecker S, Onuma Y (2016). Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial. The Lancet, 388(10059), 2479-2491. DOI: 10.1016/S0140-6736(16)32050-5.

Ellis SG, Kereiakes DJ, Metzger DC, Caputo RP, Rizik DG, Teirstein PS, Litt MR, Kini A, Kabour A, Marx SO, Popma JJ, McGreevy R, Zhang Z, Simonton C, Stone GW; ABSORB III Investigators (2015). Everolimus-eluting bioresorbable scaffolds for coronary artery disease. New England Journal of Medicine, 373(20), 1905-1915. DOI: 10.1056/NEJMoa1509038.

Ali ZA, Serruys PW, Onuma Y, Fajadet J, Sabaté M, Whitbourn R, Rapoza R, Sudhir K, Cutlip DE, Stone GW (2017). The state of the Absorb bioresorbable scaffold: consensus from an expert panel. JACC: Cardiovascular Interventions, 10(21), 2143-2159. DOI: 10.1016/j.jcin.2017.09.041.

Downloads

Published

2026-06-25